Disitamab vedotin plus toripalimab: first-line urothelial cancer: consultation records checklist

1. Submit urothelial cancer pathology and the complete HER2 IHC report to confirm the expression level
2. Provide chest, abdominal and pelvic imaging and records of metastatic sites to establish the treatment setting
3. Organise a timeline of surgery, perioperative and systemic medicines to confirm first-line eligibility
4. Prepare liver and kidney tests, blood counts and records of symptoms such as numb hands or feet to assess tolerance

Questions to clarify
- Do I meet the eligibility criteria?
- What are the separate medical and coordination service costs without Chinese health insurance or free-drug assistance?
- How are initial treatment, ongoing treatment, return travel and follow-up arranged?
- Which risks require immediate contact with the hospital?

An initial service consultation does not replace medical assessment.